Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2002-9-4
pubmed:abstractText
To evaluate the clinical efficacy and tolerability of etoricoxib in the treatment of osteoarthritis (OA) of the knee and define the clinically active dose range for further clinical trials.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1462-0324
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1052-61
pubmed:dateRevised
2007-9-6
pubmed:meshHeading
pubmed-meshheading:12209041-Adult, pubmed-meshheading:12209041-Aged, pubmed-meshheading:12209041-Aged, 80 and over, pubmed-meshheading:12209041-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:12209041-Antirheumatic Agents, pubmed-meshheading:12209041-Cyclooxygenase Inhibitors, pubmed-meshheading:12209041-Diclofenac, pubmed-meshheading:12209041-Dose-Response Relationship, Drug, pubmed-meshheading:12209041-Double-Blind Method, pubmed-meshheading:12209041-Female, pubmed-meshheading:12209041-Health Status, pubmed-meshheading:12209041-Humans, pubmed-meshheading:12209041-Male, pubmed-meshheading:12209041-Middle Aged, pubmed-meshheading:12209041-Osteoarthritis, Knee, pubmed-meshheading:12209041-Pain, pubmed-meshheading:12209041-Pain Measurement, pubmed-meshheading:12209041-Pliability, pubmed-meshheading:12209041-Pyridines, pubmed-meshheading:12209041-Severity of Illness Index, pubmed-meshheading:12209041-Sulfones, pubmed-meshheading:12209041-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
pubmed:affiliation
Clinical Pharmacology, Merck Research Laboratories, Rahway, NJ 07065, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't